IP Library Granted Patent US 9,980,831
Granted Patent B2
US 9,980,831 · App. 15/011,281 · Granted May 29, 2018

Ureteral stent

Inventors: David L. Nichols (Brownsboro, TX); Christopher A. Richardson (Athens, TX)
Assignee: FUTUREMATRIX INTERVENTIONAL
A61F2/848A61F2/0095A61F2/04A61L31/06A61M27/008A61F2002/048A61F2210/00A61F2240/001A61M25/002A61M25/0009A61M25/0102A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,980,831
App. No.
15/011,281
Granted
May 29, 2018
Kind
B2
Abstract

A ureteral stent comprises an internal portion, which comprises a first polymer, and an external portion, which comprises a second polymer. The external portion surrounds the internal portion and has a plurality of radial projections that extend along the length of the ureteral stent. The second polymer has a Shore D hardness of 20-40 Shore D. The first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.

Claims (46)

1. A ureteral stent, consisting of:

an internal portion, comprising a first polymer, and

an external portion surrounding the internal portion and forming 2-10 radial projections that extend along the length of the ureteral stent, comprising a second polymer,

wherein the second polymer has a Shore D hardness of 20-40 Shore D, and

the first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.

2. The ureteral stent of claim 1 , wherein the internal portion defines a lumen.

3. The ureteral stent of claim 1 , wherein the internal portion does not define a lumen.

4. The ureteral stent of claim 1 , wherein the ureteral stent is not coiled.

5. The ureteral stent of claim 1 , wherein the first polymer has a hardness of 35-70 Shore D.

6. The ureteral stent of claim 1 , wherein the first polymer and the second polymer consist of thermoplastic elastomers.

7. The ureteral stent of claim 1 , wherein the first polymer and the second polymer consist of polyether block amides (PEBAs).

8. The ureteral stent of claim 1 , wherein the radial projections are substantially normal to the external portion.

9. The ureteral stent of claim 1 , wherein the radial projections are curved.

10. The ureteral stent of claim 1 , wherein the radial projections have the shape of one or more lobes extending from the terminal portion of the radial projections.

11. The ureteral stent of claim 1 , wherein the ureteral stent is sterile.

12. A coated ureteral stent, comprising:

the ureteral stent of claim 1 , and

a coating on the external portion,

wherein the coating is selected from the group consisting of hydrophilic coatings, antibacterial coatings, antimicrobial coatings, and combinations thereof.

13. The ureteral stent of claim 1 , wherein the external portion forms 6 radial projections,

the first polymer has a hardness of 40 Shore D,

the second polymer has a hardness of 25 Shore D,

the first polymer and the second polymer consist of polyether block amides,

the radial projections are substantially normal to the external portion, and

the ureteral stent is sterile.

14. A kit, comprising:

a guidewire, and

the ureteral stent of claim 1 ,

wherein the guidewire and the ureteral stent are sterile.

15. The kit of claim 14 , further comprising a pusher.

16. The kit of claim 14 , further comprising a pusher,

a container,

a lubricant, and

printed instructions,

wherein the guidewire and the ureteral stent are housed in the container, and

the guidewire is pre-threaded through the ureteral stent.

17. A ureteral stent, consisting of:

an internal portion, comprising a first polymer,

an external portion surrounding the internal portion and forming 2-10 radial projections that extend along the length of the ureteral stent, comprising a second polymer, and

a middle portion comprising a third polymer,

wherein the second polymer has a Shore D hardness of 20-40 Shore D, and

the first polymer has a Shore D hardness that is at least 10 units greater than the Shore D hardness of the second polymer.

18. A coated ureteral stent, comprising:

the ureteral stent of claim 17 , and

a coating on the external portion,

wherein the coating is selected from the group consisting of hydrophilic coatings, antibacterial coatings, antimicrobial coatings, and combinations thereof.

Assignments (6)
SECURITY INTEREST Recorded Jul 24, 2023
From: BIOMERICS, LLC
To: TORONTO DOMINION (TEXAS) LLC
Reel/Frame 064357/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2021
From: FUTUREMATRIX INTERVENTIONAL, INC.
To: BIOMERICS FMI, LLC
Reel/Frame 056381/0804 →
SECURITY INTEREST Recorded Jul 24, 2019
From: BIOMERICS FMI, LLC
To: ZIONS BANCORPORATION, N.A.
Reel/Frame 049849/0380 →
SECURITY INTEREST Recorded Jun 6, 2018
From: BIOMERICS FMI, LLC
To: ZB, N.A.
Reel/Frame 045996/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2018
From: FUTUREMATRIX INTERVENTIONAL, INC.
To: BIOMERICS FMI, LLC
Reel/Frame 045989/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2016
From: NICHOLS, DAVID L.; RICHARDSON, CHRISTOPHER A.
To: FUTUREMATRIX INTERVENTIONAL
Reel/Frame 038142/0776 →
Continuity (2)
Provisional Application 62110337 · Jan 30, 2015
Related Publication 20160220397A1 · Aug 4, 2016